The effect of imatinib and nilotinib on blood calcium and blood potassium levels in chronic myeloid leukemia patient: a literature review

Imatinib and nilotinib are first-line treatments for chronic myeloid leukemia (CML) patients, which act specifically against target cells. However, these drugs may cause side effects, such as electrolyte disturbances. This literature review aimed to provide a comparison of the effects of imatinib a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Muhammad Darwin Prenggono, Alfi Yasmina, Misna Ariyah, Tenri Ashari Wanahari, Nuvita Hasrianti
Formato: article
Lenguaje:EN
Publicado: PAGEPress Publications 2021
Materias:
Acceso en línea:https://doaj.org/article/4a95a91f1fce4f65843fdb59d347e853
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!